Intestinal Absorption of Forsythoside A in in Situ Single-pass Intestinal Perfusion and in Vitro Caco-2 Cell Models

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2012 Jul 10

PMID 22773077

Citations 16

Authors

Wei Zhou

Liu-Qing DI

Juan Wang

Jin-Jun Shan

Shi-Jia Liu

Wen-Zheng Ju

Bao-Chang Cai

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the mechanisms underlying the intestinal absorption of the major bioactive component forsythoside A (FTA) extracted from Forsythiae fructus.

Methods: An in vitro Caco-2 cell model and a single-pass intestinal perfusion in situ model in SD rats were used.

Results: In the in vitro Caco-2 cell model, the mean apparent permeability value (P(app)-value) was 4.15×10(-7) cm/s in the apical-to-basolateral (AP-BL) direction. At the concentrations of 2.6-10.4 μg/mL, the efflux ratio of FTA in the bi-directional transport experiments was approximately 1.00. After the transport, >96% of the apically loaded FTA was retained on the apical side, while >97% of the basolaterally loaded FTA was retained on the basolateral side. The P(app)-values of FTA were inversely correlated with the transepithelial electrical resistance. The paracellular permeability enhancers sodium caprate and EDTA, the P-gp inhibitor verapamil and the multidrug resistance related protein (MRP) inhibitors cyclosporine and MK571 could concentration-dependently increase the Papp-values, while the uptake (OATP) transporter inhibitors diclofenac sodium and indomethacin could concentration-dependently decrease the P(app)-values. The intake transporter SGLT1 inhibitor mannitol did not cause significant change in the P(app)-values. In the in situ intestinal perfusion model, both the absorption rate constant (K(a)) and the effective permeability (P(eff)-values) following perfusion of FTA 2.6, 5.2 and 10.4 μg/mL via the duodenum, jejunum and ileum had no significant difference, although the values were slightly higher for the duodenum as compared to those in the jejunum and ileum. The low, medium and high concentrations of verapamil caused the largest increase in the P(eff)-values for duodenum, jejunum and ileum, respectively. Sodium caprate, EDTA and cyclosporine resulted in concentration-dependent increase in the P(eff)-values. Diclofenac sodium and indomethacin caused concentration-dependent decrease in the Peff-values. Mannitol did not cause significant change in the P(app)-values for the duodenum, jejunum or ileum.

Conclusion: The results suggest that the intestinal absorption of FTA may occur through passive diffusion, and the predominant absorption site may be in the upper part of small intestine. Paracellular transport route is also involved. P-gp, MRPs and OATP may participate in the absorption of FTA in the intestine. The low permeability of FTA contributes to its low oral bioavailability.

Citing Articles

Gastrointestinal absorption and its regulation of hawthorn leaves flavonoids.

Chow J, Yang X, Hu J, Yu Q, Zhong Y, Hu X Sci Rep. 2025; 15(1):658.

PMID: 39753628 PMC: 11698746. DOI: 10.1038/s41598-024-81823-y.

Comparison of intestinal absorption characteristics between rhubarb traditional Chinese medicine preparation and activity ingredients using and model.

Ta W, Yang X, Wang J, Han C, Hua R, Lu W Chin Herb Med. 2023; 15(1):117-122.

PMID: 36875442 PMC: 9975633. DOI: 10.1016/j.chmed.2022.09.004.

Oral Bioavailability-Enhancing and Anti-obesity Effects of Hydroxysafflor Yellow A in Natural Deep Eutectic Solvent.

Gao H, Zhou H, Yue S, Feng L, Guo D, Li J ACS Omega. 2022; 7(23):19225-19234.

PMID: 35721932 PMC: 9202288. DOI: 10.1021/acsomega.2c00457.

A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Martinez M, Wu F, Sinko B, Brayden D, Grass M, Kesisoglou F AAPS J. 2022; 24(3):61.

PMID: 35501528 DOI: 10.1208/s12248-022-00713-1.

The Absorption Characteristics of Nonvolatile Components in a Water Extraction From as Determined by Single-Pass Intestinal Perfusion and High-Performance Liquid Chromatography.

Yao Y, Mi W, Cao G, Yang R, Chen H, Liu Y Front Pharmacol. 2020; 11:711.

PMID: 32581779 PMC: 7291950. DOI: 10.3389/fphar.2020.00711.

References

Deli M . Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta. 2008; 1788(4):892-910. DOI: 10.1016/j.bbamem.2008.09.016. View

Liu Y, Hu M . Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos. 2002; 30(4):370-7. DOI: 10.1124/dmd.30.4.370. View

Yu L, Zeng S . Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2. J Pharm Pharmacol. 2007; 59(5):655-60. DOI: 10.1211/jpp.59.5.0005. View

Jain R, Duvvuri S, Kansara V, Mandava N, Mitra A . Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. Int J Pharm. 2007; 336(2):233-40. PMC: 3166959. DOI: 10.1016/j.ijpharm.2006.11.058. View

Motlekar N, Srivenugopal K, Wachtel M, Youan B . Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. J Pharm Pharmacol. 2006; 58(5):591-8. PMC: 1557380. DOI: 10.1211/jpp.58.5.0003. View

Walgren R, Karnaky Jr K, Lindenmayer G, Walle T . Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther. 2000; 294(3):830-6. View

Lindmark T, Kimura Y, Artursson P . Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther. 1998; 284(1):362-9. View

Salama N, Eddington N, Fasano A . Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev. 2006; 58(1):15-28. DOI: 10.1016/j.addr.2006.01.003. View

Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A . Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm. 2008; 359(1-2):70-8. DOI: 10.1016/j.ijpharm.2008.03.016. View

10.

Wolffram S, Block M, Ader P . Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr. 2002; 132(4):630-5. DOI: 10.1093/jn/132.4.630. View

11.

Zornoza T, Cano-Cebrian M, Nalda-Molina R, Guerri C, Granero L, Polache A . Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. Eur J Pharm Sci. 2004; 22(5):347-56. DOI: 10.1016/j.ejps.2004.04.004. View

12.

Rodrigues A, Curi R, Vecchia Genvigir F, Hirata M, Hirata R . The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells. Acta Pharmacol Sin. 2009; 30(7):956-64. PMC: 4006650. DOI: 10.1038/aps.2009.85. View

13.

Wang G, Pan R, Liao Y, Chen Y, Tang J, Chang Q . An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 878(1):102-6. DOI: 10.1016/j.jchromb.2009.11.029. View

14.

Wang X, Meng M, Gao L, Liu T, Xu Q, Zeng S . Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm. 2009; 378(1-2):1-8. DOI: 10.1016/j.ijpharm.2009.05.022. View

15.

Du Q, DI L, Shan J, Liu T, Zhang X . [Intestinal absorption of daphnetin by rats single pass perfusion in situ]. Yao Xue Xue Bao. 2010; 44(8):922-6. View

16.

Kusuhara H, He Z, Nagata Y, Nozaki Y, Ito T, Masuda H . Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm Res. 2003; 20(5):720-7. DOI: 10.1023/a:1023473216759. View

17.

Artursson P, Palm K, Luthman K . Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001; 46(1-3):27-43. DOI: 10.1016/s0169-409x(00)00128-9. View

18.

Artursson P . Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci. 1990; 79(6):476-82. DOI: 10.1002/jps.2600790604. View

19.

Zuo Z, Zhang L, Zhou L, Chang Q, Chow M . Intestinal absorption of hawthorn flavonoids--in vitro, in situ and in vivo correlations. Life Sci. 2006; 79(26):2455-62. DOI: 10.1016/j.lfs.2006.08.014. View

20.

Motlekar N, Srivenugopal K, Wachtel M, Youan B . Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer. Drug Dev Res. 2007; 67(2):166-174. PMC: 1948842. DOI: 10.1002/ddr.20087. View